Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or District of Columbia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to District of Columbia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. District of Columbia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Curative Labs Inc. (NPI 1508484569)

Field	Value
Entity Type	Organization
Organization	Curative Labs Inc.
Address	3330 New York Ave Ne
City	Washington
State	DC
ZIP	20002
Taxonomy	Clinical Medical Laboratory
NPI Enumerated	July 7, 2020

Payer Source	Total Paid
Medicaid	$12M
Medicare	$0

Key Findings

CURATIVE LABS INC. is effectively a single-payer Medicaid biller with no Medicare billing on file; lifetime Medicare revenue is listed as none while lifetime Medicaid revenue is $12M, indicating the provider’s revenue footprint in public programs is concentrated entirely in Medicaid. This payer concentration suggests its operations and contracting are focused on Medicaid-covered testing rather than Medicare beneficiaries.

The provider’s business appears to be laboratory testing concentrated on SARS‑CoV‑2 molecular diagnostics: the top revenue-driving codes are U0003 and U0005, which correspond to high-throughput nucleic acid detection for SARS‑CoV‑2. The code mix and large claim volumes (252.2K claims for U0003 and 160.3K claims for U0005) are consistent with an operation structured around mass COVID-19 testing rather than broad clinical laboratory services.

Revenue concentration is extremely high: the precomputed top 3 Medicaid codes account for 100.0% of the provider’s total Medicaid revenue, with U0003 alone representing $10.8M or 90.6% of the $12M total. This indicates that virtually all Medicaid revenue is driven by a single diagnostic service line (high-throughput SARS‑CoV‑2 testing), creating operational and financial dependence on that line.

Competitive standing within the state is dominant for its primary codes. CURATIVE LABS INC. ranks #1 of 12 providers in-state for U0003 at the 100th percentile and is described as an extreme outlier far above typical state volume for this code; it also ranks #1 of 6 providers for U0005 at the 100th percentile and is notably above typical state volume. These rankings indicate the provider is a major in-state supplier of Medicaid-covered high-throughput COVID-19 PCR testing.

Payment levels and revenue mix show different average paid/claim dynamics across its main codes: U0003 accounts for $10.8M revenue with an average paid/claim of $43, while U0005 contributes $1.1M with an average paid/claim of $7. The large disparity in average paid/claim alongside the dominant claim volume for U0003 suggests revenue concentration arises mainly from that code’s higher per‑claim payment and much larger volume.

The provider’s NPI was enumerated on 2020-07-07 (~6 years ago), indicating it was established during the COVID-19 pandemic period; this tenure aligns with a business model built around pandemic-era high-throughput SARS‑CoV‑2 testing and the associated Medicaid billing patterns seen in the data.

Given the absence of Medicare billing and the fact that the top 3 Medicaid codes make up 100.0% of Medicaid revenue, the entity should be considered a specialized, high-volume COVID-19 testing laboratory within the state Medicaid market rather than a diversified clinical laboratory provider. Any assessment of future revenue risk or growth should account for the heavy dependence on a narrow set of test codes and Medicaid as the sole public payer in the file.

Medicaid: Complete Services Breakdown

Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.

2 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high…	252,200	$40	$10.8M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,…	160,290	$10	$1.1M

Medicaid: Competitive Analysis & Benchmarks

How this provider's Medicaid billing volume and revenue compare to other District of Columbia providers billing the same CPT/HCPCS codes.

Claims Volume vs. District of Columbia Distribution

Curative Labs Inc. — 2 of 2 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — District of Columbia

Full comparison — all codes billed, vs. District of Columbia median

2 rows

CPT/HCPCS Code	Description	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high…	1	10	2,360	$50	$1.2M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,…	1	10	1,700	$10	$196.5K

Related Providers

Other providers that share a Tax Identification Number (TIN) with Curative Labs Inc., ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Curative Labs Inc.	CA	Clinical Medical Laboratory	$0	$87.4M
Curative Labs Inc.	TX	Clinical Medical Laboratory	$0	$20.2M

Nearby Providers

Other providers in the same ZIP code as Curative Labs Inc., ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Government Of The District Of Columbia Office Of Tax And Revenue	DC	Land Ambulance	$5.2M	$213.4M
Rcm Of Washington, Inc	DC	Intellectual Disabilities Intermediate Care Facility	$0	$53.9M
Dcps - Public Schools	DC	Local Education Agency (LEA)	$0	$46.2M
Wellness Health Services, LLC	DC	Home Health Agency	$0	$44.1M
Mcclendon Center	DC	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$31.9M
Office Of The State Superintendent Of Education	DC	Bus	$0	$30.7M
Mt&g Enterprise, Inc	DC	Developmental Disabilities Clinic/Center	$0	$24.3M
D.c. Department Of Behavioral Health	DC	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$19.7M
Amazing Love Health Services	DC	Community/Behavioral Health Agency	$0	$18.5M
Pathways To Housing Dc	DC	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$15.1M

Curative Labs Inc. — Billing Profile & Reimbursement Data

Sign up for Curative Labs Inc. — Billing Profile & Reimbursement Data policy alerts

Curative Labs Inc. — Billing Profile & Reimbursement Data

Sign up for Curative Labs Inc. — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicaid: Total Revenue Breakdown by CPT/HCPCS Code

Medicaid: Complete Services Breakdown

Medicaid: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References